ABBOTT LABORATORIES — Director's Dealing 2004

Dec 23, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-12-21

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-11-26	Common shares without par value	G	290	—	Disposed	64515	Direct
2004-12-21	Common shares without par value	M	13852	$32.6111	Acquired	78367	Direct
2004-12-21	Common shares without par value	M	17754	$33.2314	Acquired	96121	Direct
2004-12-21	Common shares without par value	M	3074	$45.4723	Acquired	99195	Direct
2004-12-21	Common shares without par value	F	29092	$46.42	Disposed	70103	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-12-21	Option (right to buy)	$32.6111	D	13852	Disposed	2010-02-10	common shares (13852)	Direct
2004-12-21	Option (right to buy)	$33.2314	D	17754	Disposed	2013-02-13	common shares (17754)	Direct
2004-12-21	Option (right to buy)	$45.4723	D	3074	Disposed	2005-04-27	common shares (3074)	Direct
2004-12-21	Option (right to buy)	$46.42	A	11357	Acquired	2010-02-10	common shares (11357)	Direct
2004-12-21	Option (right to buy)	$46.42	A	14699	Acquired	2013-02-13	common shares (14699)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	14414	Indirect
Common shares without par value	833	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 21, 2004.

F2: Reporting person disclaims beneficial ownership of all securities held by his son.

F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in a transaction exempt from Section 16 under 16(a)-11.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.